EGFR and cancer: The acquired resistance can be sorted into two kinds of alterations, one being EGFR alteration such as C797S mutation [12] and the other being alterations activating downstream signaling, bypassing EGFR, to maintain the oncogenic effect of EGFR, or starting parallel signaling pathway to promote cancer cells metastasis [13, 14].